{"id":"W2921123848","doi":"10.1016/j.pharmthera.2019.03.003","title":"Emerging drug development technologies targeting ubiquitination for cancer therapeutics","year":2019,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Guelph; University of Toronto","funders":"Canadian Institutes of Health Research; Cancer Research Society; Genome Canada","keywords":"Drug discovery; Proteasome; Cancer; Drug development; Ubiquitin; Medicine; Drug; Cancer therapy; Cancer research; Bioinformatics; Biology; Pharmacology; Cell biology; Internal medicine; Biochemistry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007110396,0.001244929,0.001567372,0.002128116,0.0002787537,0.001255417,0.0009039513,0.001256571,0.004616894],"category_scores_gemma":[0.0006506676,0.0003127249,0.0004783618,0.001910532,0.0005915784,0.001388303,0.0007674017,0.002781407,0.002422835],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008056682,"about_ca_system_score_gemma":0.0008882496,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007630487,"about_ca_topic_score_gemma":0.002382697,"domain_scores_codex":[0.9998075,0.00002969755,0.00001827688,0.00003547389,0.00008045731,0.000028614],"domain_scores_gemma":[0.999725,0.0001292787,0.00003758917,0.00001148135,0.00006395085,0.00003266062],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001153614,0.0001084935,0.00008307149,0.008399458,0.00006432442,0.0001911593,0.0000235565,0.0005581647,0.004160841,0.006582525,0.04266807,0.9370448],"study_design_scores_gemma":[0.00003451905,0.0001137385,0.0003123652,0.001418493,0.00009190485,0.0007084989,0.00002281683,0.0001989069,0.001053204,0.002874843,0.9931526,0.00001807232],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001212805,0.996727,0.0004625292,0.0003496327,0.0003303475,0.00000901653,0.00002970795,0.00002027097,0.001950196],"genre_scores_gemma":[0.0008058981,0.9964796,0.0005753312,0.0004186177,0.0002642096,0.00001229897,0.00005271106,0.000002928841,0.001388415],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004616894,"threshold_uncertainty_score":0.01544499,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08099226102202954,"score_gpt":0.3933408033563059,"score_spread":0.3123485423342763,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}